Acetic Acid → (2-{4-[6-Ethyl-7-methyl-3-oxo-4-(2-trimethylsilanyl-ethoxy)-1,3-dihydro-isobenzofuran-5-yl]-2-methyl-but-2-enylamino}-ethyl)-phosphonic acid diethyl ester

HRID 272204노트

반응식

HRID 272204 반응식
[CH2:1]([C:3]1[C:11]([CH3:12])=[C:10]2[C:6]([C:7](=[O:13])[O:8][CH2:9]2)=[C:5]([O:14][CH2:15][CH2:16][Si:17]([CH3:20])([CH3:19])[CH3:18])[C:4]=1[CH2:21][CH:22]=[C:23]([CH3:26])[CH:24]=O)[CH3:2].[NH2:27][CH2:28][CH2:29][P:30](=[O:33])([OH:32])[OH:31].[C:34](O)(=O)[CH3:35].[C:38](O[BH-](OC(=O)C)OC(=O)C)(=O)[CH3:39].[Na+]>CN(C=O)C>[CH2:38]([O:33][P:30]([CH2:29][CH2:28][NH:27][CH2:26][C:23]([CH3:24])=[CH:22][CH2:21][C:4]1[C:5]([O:14][CH2:15][CH2:16][Si:17]([CH3:19])([CH3:18])[CH3:20])=[C:6]2[C:10](=[C:11]([CH3:12])[C:3]=1[CH2:1][CH3:2])[CH2:9][O:8][C:7]2=[O:13])(=[O:32])[O:31][CH2:34][CH3:35])[CH3:39]

참가 물질

6

실험 절차

4-[6-Ethyl-7-methyl-3-oxo-4-(2-trimethylsilanyl-ethoxy)-1,3-dihydro-isobenzofuran-5-yl]-2-methyl-but-2-enal (19.7 mg, 0.052 mmol) and aminoethylphosphonic acid diethylesteroxalate salt (15.6 mg, 0.057 mmol) were dissolved in DMF (0.5 mL). Acetic acid (15.7 mg, 0.263 mmol) was added, followed by sodium triacetoxyborohydride (22.3 mg, 0.105 mmol). After 4 hours, the crude reaction mixture was purified by RP-HPLC (eluent: water/MeCN) to provide 27.7 mg (97%) of the desired product after lyophilization. 1H NMR (300 MHz, CDCl3): δ=0.04 (s, 9H), 1.14 (t, J=7.5 Hz, 3H), 1.26 (m, 2H), 1.30 (t, J=7.2 Hz, 6H), 1.95 (s, 3H), 2.19 (s, 3H), 2.23 (m, 2H), 2.68 (q, J=7.5 Hz, 2H), 3.18 (m, 2H), 3.53 (s, 2H), 4.13 (m, 4H), 4.28 (m, 2H), 5.15 (s, 2H), 5.51 (m, 1H) ppm; 31P NMR (121 MHz, CDCl3): δ=27.39 ppm; MS=540 [M++1].

후처리

  1. customthe crude reaction mixture
  2. customwas purified by RP-HPLC (eluent: water/MeCN)

출처 및 근거

ORD 기록
ord-59bebf05eb09431089aa6b2e030c30e2
출처 데이터셋
uspto-grants-2008_11
특허 번호
US07452901B2

반응 노트

불러오는 중…